ADVICENNE (EPA:ADVIC) | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
ADVICENNE

PRESS RELEASE

published on 07/28/2025 at 07:30, 4 months 8 days ago

Informations privilégiées / Autres communiqués
Advicenne obtient l’AMM et le remboursement de Sibnayal en Arabie Saoudite pour le traitement des maladies rénales rares. Collaboration avec Taïba Healthcare

Arabie Saoudite Advicenne Maladies Rénales Rares AMM Sibnayal
BRIEF

published on 07/25/2025 at 07:35, 4 months 10 days ago

Advicenne Announces 9% Revenue Growth for H1 2025

Growth Turnover Advicenna Sibnayal® Pharmaceutical Markets
BRIEF

published on 07/25/2025 at 07:35, 4 months 10 days ago

Advicenne Annonce une Croissance de 9% de son Chiffre d'Affaires pour le S1 2025

Chiffre D'affaires Croissance Advicenne Sibnayal® Marchés Pharmaceutiques
PRESS RELEASE

published on 07/25/2025 at 07:30, 4 months 11 days ago

Inside Information / Other news releases
Advicenne reports H1 2025 sales of €2.6 million, with direct sales rising 17% and Sibnayal® sales in Europe up 90% compared to H1 2024. Company's cash flow horizon extends to Q3 2026

Cash Flow Pharmaceutical Advicenne Sibnayal H1 2025 Sales
PRESS RELEASE

published on 07/25/2025 at 07:30, 4 months 11 days ago

Informations privilégiées / Autres communiqués
Advicenne publie un chiffre d'affaires en hausse de 9% au S1 2025, avec des ventes de Sibnayal® en progression de 17%. La société dispose de trésorerie jusqu'au 3ème trimestre 2026

Chiffre D'affaires Trésorerie Advicenne S1 2025 Sibnayal®
BRIEF

published on 07/21/2025 at 20:57, 4 months 14 days ago

Advicenne lève 2,6 millions d'euros pour renforcer sa capacité financière

Marché Financier Augmentation De Capital Bpifrance Advicenne Maladies Rénales
BRIEF

published on 07/21/2025 at 20:57, 4 months 14 days ago

Advicenne raises 2.6 million euros to strengthen its financial capacity

Capital Increase Financial Market Bpifrance Kidney Diseases Advicenna
PRESS RELEASE

published on 07/21/2025 at 20:52, 4 months 14 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Advicenne lève 2,6 millions d’euros grâce à une augmentation de capital, étend sa visibilité financière jusqu'à fin T3 2026 et renforce sa situation financière. Bpifrance détient désormais 23,95% du capital

Augmentation De Capital Santé Bpifrance Advicenne Visibilité Financière
BRIEF

published on 03/27/2025 at 19:17, 8 months 8 days ago

Advicenne annonce une croissance solide et des projets futurs pour 2025

Amélioration Des Flux De Trésorerie Perspectives 2025 Résultats Financiers D'Advicenne Croissance Des Ventes De Sibnayal Progrès Réglementaires ADV7103
BRIEF

published on 03/27/2025 at 19:17, 8 months 8 days ago

Advicenne Reports Solid Growth and Future Plans for 2025

Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 34 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 4 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 44 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 9 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 19 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 20 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE